共 50 条
- [31] Prevalence of Chronic Kidney Disease and Associated Risk Factors, and Risk of End-Stage Renal Disease: Data from the PREVADIAB Study NEPHRON CLINICAL PRACTICE, 2011, 119 (01): : C35 - C40
- [38] Effects of spironolactone on cardiovascular outcomes in chronic kidney disease and end-stage renal disease patients INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (02): : 794 - 803
- [39] Evaluation of Warfarin Dose Requirements in Patients with Chronic Kidney Disease and End-Stage Renal Disease PHARMACOTHERAPY, 2014, 34 (07): : 695 - 702